- Report
- August 2023
- 1300 Pages
Global
From €8434EUR$8,900USD£7,118GBP
- Report
- August 2023
- 51 Pages
South Korea
From €569EUR$600USD£480GBP
- Report
- August 2023
- 51 Pages
Mexico
From €569EUR$600USD£480GBP
- Report
- August 2023
- 51 Pages
Canada
From €569EUR$600USD£480GBP
- Report
- August 2023
- 51 Pages
Saudi Arabia
From €569EUR$600USD£480GBP
From €569EUR$600USD£480GBP
- Report
- August 2023
- 51 Pages
Germany
From €569EUR$600USD£480GBP
- Report
- August 2023
- 51 Pages
France
From €569EUR$600USD£480GBP
- Report
- August 2023
- 51 Pages
United States
From €569EUR$600USD£480GBP
- Report
- August 2023
- 51 Pages
Australia
From €569EUR$600USD£480GBP
- Report
- August 2023
- 51 Pages
Japan
From €569EUR$600USD£480GBP
- Report
- August 2023
- 51 Pages
Turkey
From €569EUR$600USD£480GBP
- Report
- August 2023
- 51 Pages
Italy
From €569EUR$600USD£480GBP
- Report
- August 2023
- 51 Pages
United Kingdom
From €569EUR$600USD£480GBP
- Report
- August 2023
- 51 Pages
China
From €569EUR$600USD£480GBP
- Report
- August 2023
- 51 Pages
Switzerland
From €569EUR$600USD£480GBP
- Report
- August 2023
- 51 Pages
Argentina
From €569EUR$600USD£480GBP
- Report
- August 2023
- 51 Pages
Brazil
From €569EUR$600USD£480GBP
- Report
- August 2023
- 51 Pages
Israel
From €569EUR$600USD£480GBP
- Report
- August 2023
- 51 Pages
Colombia
From €569EUR$600USD£480GBP

Gene Editing is a technology used in genomics to modify the genetic material of living organisms. It is used to make changes to the DNA sequence of a gene, such as deleting, inserting, or replacing a gene. This technology has been used to create genetically modified organisms, which have been used in research and medical applications. It has also been used to create gene therapies, which are treatments that use gene editing to modify a patient's genetic material to treat a disease.
Gene Editing is a rapidly growing market, with many companies developing new technologies and applications. Companies such as Editas Medicine, CRISPR Therapeutics, Intellia Therapeutics, and Sangamo Therapeutics are leading the way in developing gene editing technologies and treatments. Other companies such as Cellectis, Caribou Biosciences, and Twist Bioscience are also developing gene editing technologies and products. Show Less Read more